Deeptech MSV

Main Sequence Ventures is a leading Australian deep technology investment fund, established in 2017 by Australia's national science agency, CSIRO. The firm's core mission is to back ambitious founders who are transforming breakthrough scientific and engineering discoveries into globally significant companies that address humanity's most pressing challenges. Main Sequence Ventures focuses on areas such as decarbonisation, healthcare, next-generation computing, industrial productivity, the global food system, and space technology, recognising that deep technology often requires patient capital and longer development cycles than traditional tech ventures.

What sets Main Sequence Ventures apart is its unique 'Venture Science' model, which combines deep scientific knowledge with industry expertise and capital to build entirely new industries and ecosystems. This approach involves not only seeking out promising deep tech companies but also actively co-founding new ventures from novel research. The firm provides more than just capital, offering hands-on support and a services offering to assist founders in navigating the complexities of commercialising scientific breakthroughs.

Key achievements include surpassing AU$1 billion in funds under management, with its third fund raising AU$450 million. Since its inception, Main Sequence Ventures has backed 53 companies, which have collectively created over 2,100 new jobs and achieved a market value exceeding AU$6.8 billion. Notable investments span diverse sectors, including advanced navigation, quantum computing, and sustainable material innovation. The firm also runs initiatives such as 'Atmosphere', a platform designed to nurture early-stage deep tech startups and help them grow into world-changing businesses.

The leadership team at Main Sequence Ventures comprises experienced investors and entrepreneurs with a deep understanding of science and technology commercialisation. Co-founder and Managing Partner Bill Bartee, alongside partners such as Martin Duursma, Mike Zimmerman, Phil Morle, Gabrielle Munzer, Elaine Stead, and Emerald Scofield, guide the firm's investment strategy and support its portfolio companies. Their collective expertise and belief in the transformative power of deep tech underpin Main Sequence Ventures' commitment to fostering Australia's innovation ecosystem and addressing global challenges.